S&P 500   3,723.61 (-2.52%)
DOW   30,548.98 (-2.31%)
QQQ   302.91 (-2.02%)
AAPL   119.78 (-1.87%)
MSFT   226.23 (-0.58%)
FB   256.29 (+0.34%)
GOOGL   2,025.69 (+0.71%)
TSLA   608.95 (-6.77%)
AMZN   2,980.00 (-0.83%)
NVDA   490.11 (-4.31%)
BABA   230.38 (-2.49%)
CGC   30.65 (-7.79%)
GE   13.36 (-0.60%)
MU   83.25 (-6.58%)
NIO   38.95 (-6.21%)
AMD   77.67 (-3.95%)
T   28.87 (+0.52%)
F   11.84 (-2.71%)
ACB   9.64 (-7.84%)
DIS   186.30 (-3.10%)
BA   222.90 (-2.48%)
NFLX   513.30 (-1.42%)
PFE   34.08 (-0.90%)
S&P 500   3,723.61 (-2.52%)
DOW   30,548.98 (-2.31%)
QQQ   302.91 (-2.02%)
AAPL   119.78 (-1.87%)
MSFT   226.23 (-0.58%)
FB   256.29 (+0.34%)
GOOGL   2,025.69 (+0.71%)
TSLA   608.95 (-6.77%)
AMZN   2,980.00 (-0.83%)
NVDA   490.11 (-4.31%)
BABA   230.38 (-2.49%)
CGC   30.65 (-7.79%)
GE   13.36 (-0.60%)
MU   83.25 (-6.58%)
NIO   38.95 (-6.21%)
AMD   77.67 (-3.95%)
T   28.87 (+0.52%)
F   11.84 (-2.71%)
ACB   9.64 (-7.84%)
DIS   186.30 (-3.10%)
BA   222.90 (-2.48%)
NFLX   513.30 (-1.42%)
PFE   34.08 (-0.90%)
S&P 500   3,723.61 (-2.52%)
DOW   30,548.98 (-2.31%)
QQQ   302.91 (-2.02%)
AAPL   119.78 (-1.87%)
MSFT   226.23 (-0.58%)
FB   256.29 (+0.34%)
GOOGL   2,025.69 (+0.71%)
TSLA   608.95 (-6.77%)
AMZN   2,980.00 (-0.83%)
NVDA   490.11 (-4.31%)
BABA   230.38 (-2.49%)
CGC   30.65 (-7.79%)
GE   13.36 (-0.60%)
MU   83.25 (-6.58%)
NIO   38.95 (-6.21%)
AMD   77.67 (-3.95%)
T   28.87 (+0.52%)
F   11.84 (-2.71%)
ACB   9.64 (-7.84%)
DIS   186.30 (-3.10%)
BA   222.90 (-2.48%)
NFLX   513.30 (-1.42%)
PFE   34.08 (-0.90%)
S&P 500   3,723.61 (-2.52%)
DOW   30,548.98 (-2.31%)
QQQ   302.91 (-2.02%)
AAPL   119.78 (-1.87%)
MSFT   226.23 (-0.58%)
FB   256.29 (+0.34%)
GOOGL   2,025.69 (+0.71%)
TSLA   608.95 (-6.77%)
AMZN   2,980.00 (-0.83%)
NVDA   490.11 (-4.31%)
BABA   230.38 (-2.49%)
CGC   30.65 (-7.79%)
GE   13.36 (-0.60%)
MU   83.25 (-6.58%)
NIO   38.95 (-6.21%)
AMD   77.67 (-3.95%)
T   28.87 (+0.52%)
F   11.84 (-2.71%)
ACB   9.64 (-7.84%)
DIS   186.30 (-3.10%)
BA   222.90 (-2.48%)
NFLX   513.30 (-1.42%)
PFE   34.08 (-0.90%)
Log in
NASDAQ:AXSM

Axsome Therapeutics Short Interest Ratio and Short Volume

$67.79
-2.39 (-3.41 %)
(As of 03/4/2021 01:41 PM ET)
Add
Compare
Today's Range
$67.13
Now: $67.79
$70.30
50-Day Range
$67.36
MA: $73.32
$80.44
52-Week Range
$35.44
Now: $67.79
$109.53
Volume16,164 shs
Average Volume293,829 shs
Market Capitalization$2.53 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.59

Short Interest

Axsome Therapeutics (NASDAQ:AXSM) Short Interest Data

Current Short Volume3,080,000 shares
Previous Short Volume3,370,000 shares
Change Vs. Previous Month:-8.61%
Dollar Volume Sold Short$207.47 million
Short Interest Ratio / Days to Cover10.0
Last Record DateFebruary, 12 2021
Outstanding Shares33,310,000 shares
Float Size29,370,000 shares
Short Percent of Float10.49%
Today's Trading Volume16,164 shares
Average Trading Volume293,829 shares
Today's Volume Vs. Average-94.50%

Short Interest Over Time


Axsome Therapeutics (NASDAQ:AXSM) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20213,080,000 shares $207.47 million -8.6%10.5%10 $67.36
1/29/20213,370,000 shares $252.75 million +0.6%11.5%10.7 $75.00
1/15/20213,350,000 shares $233.96 million -3.2%11.4%10.7 $69.84
12/31/20203,380,000 shares $263.44 million +1.2%11.5%10.7 $77.94
12/15/20203,380,000 shares $265.60 million +1.2%11.5%10.7 $78.58
11/30/20203,340,000 shares $261.42 million -3.5%11.4%9.3 $78.27
11/15/20203,460,000 shares $250.82 million +0.3%11.8%9.5 $72.49
10/30/20203,450,000 shares $255.92 million -4.7%11.8%9.3 $74.18
10/15/20203,620,000 shares $246.41 million -5.2%12.4%9.4 $68.07
9/30/20203,820,000 shares $288.75 million +4.1%13.1%9.4 $75.59
9/15/20203,670,000 shares $282.66 million -4.4%12.6%7.8 $77.02
8/31/20203,840,000 shares $285.16 million -1.0%13.1%8.4 $74.26
8/14/20203,880,000 shares $281.30 million +0.3%13.3%8.1 $72.50
7/31/20203,870,000 shares $313.47 million No Change13.5%7.3 $81.00
7/15/20203,870,000 shares $276.05 million +0.3%13.5%5.7 $71.33
6/30/20203,860,000 shares $298.57 million +9.0%13.4%5.1 $77.35
6/15/20203,540,000 shares $299.84 million +4.1%12.3%4.3 $84.70
5/29/20203,400,000 shares $256.39 million -0.9%11.8%3.5 $75.41
5/15/20203,430,000 shares $264.04 million -4.5%11.9%3.4 $76.98
4/30/20203,590,000 shares $281.64 million -14.9%12.5%3.6 $78.45
4/15/20204,220,000 shares $376.64 million +8.5%14.6%4.8 $89.25
3/31/20203,890,000 shares $297.20 million -6.5%13.5%4.4 $76.40
3/13/20204,158,800 shares $233.52 million +10.0%20.1%5.5 $56.15
2/28/20203,780,000 shares $241.58 million -4.1%18.2%3.3 $63.91
2/14/20203,940,000 shares $305.39 million -3.0%13.8%3.2 $77.51

Axsome Therapeutics (NASDAQ:AXSM) Short Interest FAQ

speech bubbles
speech bubbles











What is Axsome Therapeutics' current short interest?

Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 3,080,000 shares of AXSM short. 10.49% of Axsome Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for Axsome Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Axsome Therapeutics currently has a short interest ratio of 10.0.

What is a good short interest percentage for Axsome Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.49% of Axsome Therapeutics' floating shares are currently sold short.

Is Axsome Therapeutics' short interest increasing or decreasing?

Axsome Therapeutics saw a drop in short interest in February. As of February 12th, there was short interest totaling 3,080,000 shares, a drop of 8.6% from the previous total of 3,370,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Axsome Therapeutics' float size?

Axsome Therapeutics currently has issued a total of 37,344,000 shares. Some of Axsome Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Axsome Therapeutics currently has a public float of 29,370,000 shares.

How does Axsome Therapeutics' short interest compare to its competitors?

10.49% of Axsome Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Axsome Therapeutics: Dr. Reddy's Laboratories Limited (0.00%), Mirati Therapeutics, Inc. (0.00%), BridgeBio Pharma, Inc. (11.95%), Jazz Pharmaceuticals plc (7.60%), Ultragenyx Pharmaceutical Inc. (0.00%), Ascendis Pharma A/S (0.00%), Arrowhead Pharmaceuticals, Inc. (0.00%), ACADIA Pharmaceuticals Inc. (0.00%), Ionis Pharmaceuticals, Inc. (5.97%), and United Therapeutics Co. (4.02%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Axsome Therapeutics stock?

Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. Axsome Therapeutics' stock is trading down $2.39 today. To short Axsome Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Axsome Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Axsome Therapeutics?

A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further.

How often is Axsome Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.